Related Experiment Videos
Different telomere damage signaling pathways in human and mouse cells
Agata Smogorzewska1, Titia de Lange
1Laboratory for Cell Biology and Genetics, The Rockefeller University, 1230 York Avenue, NY 10021, USA.
The EMBO Journal
|August 10, 2002
Summary
Removing TRF2 protein from telomeres triggers premature cell aging (senescence) in human cells, similar to natural aging. Mouse cells show a different response, highlighting species differences in telomere signaling.
Area of Science:
- Cellular senescence
- Telomere biology
- Cancer research
Background:
- Programmed telomere shortening acts as a tumor suppressor mechanism by limiting cell replication.
- Critical telomere length induces senescence via p53 or p16/RB pathways in human cells.
- Both p53 and p16/RB pathways must be suppressed to overcome senescence in aged human cells.
Purpose of the Study:
- To investigate the consequences of TRF2 removal from human telomeres.
- To compare telomere dysfunction responses between human and mouse cells.
Main Methods:
- Removal of TRF2 (Telomere Repeat-Binding Factor 2) from human telomeres.
- Observation of induced premature senescence and cell cycle arrest.
- Analysis of p53 and p16/RB pathway involvement in human and mouse cells.
Main Results:
- TRF2 removal induced immediate premature senescence in human cells, mimicking replicative senescence.
- Human cell senescence was mediated by either the p53 or the p16/RB pathway.
- Mouse cells exhibited growth arrest and senescence upon telomere de-protection, but p53 loss fully abrogated this, indicating p16/RB is inactive in mouse telomere response.
Conclusions:
- Telomere de-protection via TRF2 removal triggers senescence through distinct pathways in human cells.
- A fundamental difference exists in telomere damage signaling between human and mouse cells.
- Findings impact the utility of mouse models for studying the telomere tumor suppressor pathway.